Contact

All Stories

  1. Discovery of the Aminated Quinoxalines as Potential Active Molecules

    Article • Letters in Drug Design & Discovery, December 2024, Bentham Science Publishers

    emel mataracı kara, Assoc. Prof. Dr. Belgin Sever

  2. Synthesis, in silico and in vitro evaluation of new 3,5-disubstituted-1,2,4-oxadiazole derivatives as carbonic anhydrase inhibitors and cytotoxic agents

    Article • Journal of Molecular Structure, March 2023, Elsevier

    Assoc. Prof. Dr. Belgin Sever

  3. Studies on 1,4-Quinone Derivatives Exhibiting Anti-Leukemic Activity along with Anti-Colorectal and Anti-Breast Cancer Effects

    Article • Molecules, December 2022, MDPI AG

    Assoc. Prof. Dr. Belgin Sever

  4. Design, semi-synthesis and examination of new gypsogenin derivatives against leukemia via Abl tyrosine kinase inhibition and apoptosis induction

    Article • International Journal of Biological Macromolecules, December 2022, Elsevier

    Assoc. Prof. Dr. Belgin Sever

  5. In vitro evaluation of 2-pyrazoline derivatives as DPP-4 inhibitors

    Article • Turkish Journal of Biochemistry, November 2022, De Gruyter

    Assoc. Prof. Dr. Belgin Sever

  6. In Vitro Cytotoxicity Evaluation of Plastoquinone Analogues against Colorectal and Breast Cancers along with In Silico Insights

    Article • Pharmaceuticals, October 2022, MDPI AG

    Assoc. Prof. Dr. Belgin Sever

  7. Identification of New L-Heptanoylphosphatidyl Inositol Pentakisphosphate Derivatives Targeting the Interaction with HIV-1 Gag by Molecular Modelling Studies

    Article • Pharmaceuticals, October 2022, MDPI AG

    Assoc. Prof. Dr. Belgin Sever

  8. Evaluation of anti-glioma effects of benzothiazoles as efficient apoptosis inducers and DNA cleaving agents

    Article • Molecular and Cellular Biochemistry, October 2022, Springer Science + Business Media

    Assoc. Prof. Dr. Belgin Sever

  9. An investigation of bacteriocin nisin anti-cancer effects and FZD7 protein interactions in liver cancer cells

    Article • Chemico-Biological Interactions, October 2022, Elsevier

    Assoc. Prof. Dr. Belgin Sever

  10. A new series of thiosemicarbazone‐based anti‐inflammatory agents exerting their action through cyclooxygenase inhibition

    Article • Archiv der Pharmazie, May 2022, Wiley

    Assoc. Prof. Dr. Belgin Sever

  11. Comprehensive Research on Past and Future Therapeutic Strategies Devoted to Treatment of Amyotrophic Lateral Sclerosis

    Article • International Journal of Molecular Sciences, February 2022, MDPI AG

    Assoc. Prof. Dr. Belgin Sever

  12. In Vitro and In Silico Study of Analogs of Plant Product Plastoquinone to Be Effective in Colorectal Cancer Treatment

    Article • Molecules, January 2022, MDPI AG

    Assoc. Prof. Dr. Belgin Sever

  13. A New Series of Indeno[1,2-c]pyrazoles as EGFR TK Inhibitors for NSCLC Therapy

    Article • Molecules, January 2022, MDPI AG

    Assoc. Prof. Dr. Belgin Sever

  14. A New Series of Triazolothiadiazines as Potential Anticancer Agents for Targeted Therapy of Non-Small Cell Lung and Colorectal Cancers: Design, Synthesis, In silico and In vitro Studies Providing Mechanistic Insight into Their Anticancer Potencies

    Article • Medicinal Chemistry, December 2021, Bentham Science Publishers

    Assoc. Prof. Dr. Belgin Sever

  15. EGFR-Targeted Pentacyclic Triterpene Analogues for Glioma Therapy

    Article • International Journal of Molecular Sciences, October 2021, MDPI AG

    Assoc. Prof. Dr. Belgin Sever

  16. Novel metabolic enzyme inhibitors designed through the molecular hybridization of thiazole and pyrazoline scaffolds

    Article • Archiv der Pharmazie, September 2021, Wiley

    Assoc. Prof. Dr. Belgin Sever

  17. Design, synthesis and investigation of the mechanism of action underlying anti-leukemic effects of the quinolinequinones as LY83583 analogs

    Article • Bioorganic Chemistry, September 2021, Elsevier

    Assoc. Prof. Dr. Belgin Sever

  18. Identification of a new class of potent aldose reductase inhibitors: Design, microwave-assisted synthesis, in vitro and in silico evaluation of 2-pyrazolines

    Article • Chemico-Biological Interactions, August 2021, Elsevier

    Assoc. Prof. Dr. Belgin Sever

  19. Structure based design, synthesis, and evaluation of anti-CML activity of the quinolinequinones as LY83583 analogs

    Article • Chemico-Biological Interactions, August 2021, Elsevier

    Assoc. Prof. Dr. Belgin Sever

  20. An extensive research on aldose reductase inhibitory effects of new 4H-1,2,4-triazole derivatives

    Article • Journal of Molecular Structure, January 2021, Elsevier

    Assoc. Prof. Dr. Belgin Sever

  21. In Vitro and In Silico Evaluation of Anticancer Activity of New Indole-Based 1,3,4-Oxadiazoles as EGFR and COX-2 Inhibitors

    Article • Molecules, November 2020, MDPI AG

    Assoc. Prof. Dr. Belgin Sever, Doha Ellakwa

  22. Thiazolyl-pyrazoline derivatives: In vitro and in silico evaluation as potential acetylcholinesterase and carbonic anhydrase inhibitors

    Article • International Journal of Biological Macromolecules, November 2020, Elsevier

    Assoc. Prof. Dr. Belgin Sever

  23. Pyrazole Incorporated New Thiosemicarbazones: Design, Synthesis and Investigation of DPP-4 Inhibitory Effects

    Article • Molecules, October 2020, MDPI AG

    Assoc. Prof. Dr. Belgin Sever

  24. Design, Synthesis, In vitro and In silico Evaluation of New Hydrazonebased Antitumor Agents as Potent Akt Inhibitors

    Article • Letters in Drug Design & Discovery, October 2020, Bentham Science Publishers

    Assoc. Prof. Dr. Belgin Sever, EMİNE MERVE GÜNGÖR

  25. Synthesis of New Bis-pyrazolines Endowed with Potent Antifungal Activity against Candida albicans and Aspergillus niger

    Article • Letters in Drug Design & Discovery, October 2020, Bentham Science Publishers

    Assoc. Prof. Dr. Belgin Sever

  26. A new series of benzoxazole‐based SIRT1 modulators for targeted therapy of non‐small‐cell lung cancer

    Article • Archiv der Pharmazie, September 2020, Wiley

    Assoc. Prof. Dr. Belgin Sever

  27. Design, synthesis and biological evaluation of new bis(thiosemicarbazone) derivatives as potential targeted anticancer agents for non-small cell lung cancer

    Article • Journal of Research in Pharmacy, September 2020, ASOS Yayinevi

    Assoc. Prof. Dr. Belgin Sever

  28. In vitro and in silico assessment of antiproliferative activity of new acetamides bearing 1,3,4-oxadiazole and pyrimidine cores via COX inhibition

    Article • Journal of Research in Pharmacy, September 2020, ASOS Yayinevi

    Assoc. Prof. Dr. Belgin Sever

  29. Design, synthesis, in vitro and in silico investigation of aldose reductase inhibitory effects of new thiazole-based compounds

    Article • Bioorganic Chemistry, September 2020, Elsevier

    Assoc. Prof. Dr. Belgin Sever

  30. A New Series of Antileukemic Agents: Design, Synthesis, In Vitro and In Silico Evaluation of Thiazole-Based ABL1 Kinase Inhibitors

    Article • Anti-Cancer Agents in Medicinal Chemistry, August 2020, Bentham Science Publishers

    Assoc. Prof. Dr. Belgin Sever, Doha Ellakwa

  31. In vitro and in silico studies on AChE inhibitory effects of a series of donepezil-like arylidene indanones

    Article • Turkish Journal of Biochemistry, July 2020, De Gruyter

    Assoc. Prof. Dr. Belgin Sever

  32. A Series of Furan-based Hydrazones: Design, Synthesis, and Evaluation of Antimicrobial Activity, Cytotoxicity and Genotoxicity

    Article • Letters in Drug Design & Discovery, March 2020, Bentham Science Publishers

    Assoc. Prof. Dr. Belgin Sever

  33. Investigation of the inhibitory effects of isoindoline-1,3-dion derivatives on hCA-I and hCA-II enzyme activities

    Article • Journal of Molecular Structure, December 2019, Elsevier

    Assoc. Prof. Dr. Belgin Sever

  34. Design, synthesis and biological evaluation of a new series of thiazolyl-pyrazolines as dual EGFR and HER2 inhibitors

    Article • European Journal of Medicinal Chemistry, November 2019, Elsevier

    Assoc. Prof. Dr. Belgin Sever

  35. Biological evaluation of a series of benzothiazole derivatives as mosquitocidal agents

    Article • Open Chemistry, June 2019, De Gruyter

    Assoc. Prof. Dr. Belgin Sever

  36. Comprehensive Study on Thiadiazole-Based Anticancer Agents Inducing Cell Cycle Arrest and Apoptosis/Necrosis Through Suppression of Akt Activity in Lung Adenocarcinoma and Glioma Cells

    Article • Turkish Journal of Pharmaceutical Sciences, June 2019, Journal of Clinical Research of Pediatric Endocrinology

    Assoc. Prof. Dr. Belgin Sever

  37. Synthesis and Evaluation of a New Series of Arylidene Indanones as Potential Anticancer Agents

    Article • Anti-Cancer Agents in Medicinal Chemistry, January 2019, Bentham Science Publishers

    Assoc. Prof. Dr. Belgin Sever

  38. Synthesis and Evaluation of a Series of 1,3,4-Thiadiazole Derivatives as Potential Anticancer Agents

    Article • Anti-Cancer Agents in Medicinal Chemistry, December 2018, Bentham Science Publishers

    Assoc. Prof. Dr. Belgin Sever

  39. Antiproliferative Effects of a Series of Pyrazolines on Lung Cancer

    Article • Proceedings, December 2018, MDPI AG

    Assoc. Prof. Dr. Belgin Sever

  40. Design, synthesis and in vitro evaluation of new thiosemicarbazone derivatives as potential anticancer agents

    Article • Journal of Research in Pharmacy, November 2018, Marmara Pharmaceutical Journal

    Assoc. Prof. Dr. Belgin Sever

  41. Design, Synthesis, and Neuroprotective Effects of a Series of Pyrazolines against 6-Hydroxydopamine-Induced Oxidative Stress

    Article • Molecules, August 2018, MDPI AG

    Assoc. Prof. Dr. Belgin Sever

  42. Design, synthesis, in vitro and in silico evaluation of a new series of oxadiazole-based anticancer agents as potential Akt and FAK inhibitors

    Article • European Journal of Medicinal Chemistry, July 2018, Elsevier

    Assoc. Prof. Dr. Belgin Sever

  43. A Comprehensive Study on Thiadiazole-Based Anticancer Agents Inducing Cell Cycle Arrest and Apoptosis/Necrosis through Suppression of Akt Activity in Lung Adenocarcinoma and Glioma Cells

    Article • Turkish Journal of Pharmaceutical Sciences, June 2018, Journal of Clinical Research of Pediatric Endocrinology

    Assoc. Prof. Dr. Belgin Sever

  44. Design, Synthesis, and Evaluation of a New Series of Thiazole-Based Anticancer Agents as Potent Akt Inhibitors

    Article • Molecules, May 2018, MDPI AG

    Assoc. Prof. Dr. Belgin Sever

  45. Design, synthesis, in vitro and in silico evaluation of new pyrrole derivatives as monoamine oxidase inhibitors

    Article • Archiv der Pharmazie, May 2018, Wiley

    Assoc. Prof. Dr. Belgin Sever

  46. In Silico Molecular Docking And Adme Studies Of 1,3,4-Thiadiazole Derivatives In Relation To In Vitro Pon1 Activity

    Article • Current Computer - Aided Drug Design, May 2018, Bentham Science Publishers

    Assoc. Prof. Dr. Belgin Sever

  47. New Benzodioxole-Based Pyrazoline Derivatives: Synthesis and Anticandidal, In Silico ADME, Molecular Docking Studies

    Article • Letters in Drug Design & Discovery, March 2018, Bentham Science Publishers

    Assoc. Prof. Dr. Belgin Sever

  48. Design, Synthesis, and Biological Evaluation of Novel 1,3,4-Thiadiazole Derivatives as Potential Antitumor Agents against Chronic Myelogenous Leukemia: Striking Effect of Nitrothiazole Moiety

    Article • Molecules, December 2017, MDPI AG

    Assoc. Prof. Dr. Belgin Sever

  49. A New Series of Pyrrole-Based Chalcones: Synthesis and Evaluation of Antimicrobial Activity, Cytotoxicity, and Genotoxicity

    Article • Molecules, November 2017, MDPI AG

    Assoc. Prof. Dr. Belgin Sever

  50. Synthesis and Biological Evaluation of New Quinoline-Based Thiazolyl Hydrazone Derivatives as Potent Antifungal and Anticancer Agents

    Article • Letters in Drug Design & Discovery, October 2017, Bentham Science Publishers

    Assoc. Prof. Dr. Belgin Sever

  51. Synthesis of New Thiazolyl-Pyrazoline Derivatives and Evaluation of Their Antimicrobial, Cytotoxic and Genotoxic Effects

    Article • Letters in Drug Design & Discovery, September 2017, Bentham Science Publishers

    Assoc. Prof. Dr. Belgin Sever

  52. Synthesis and Evaluation of New Oxadiazole, Thiadiazole, and Triazole Derivatives as Potential Anticancer Agents Targeting MMP-9

    Article • Molecules, July 2017, MDPI AG

    Assoc. Prof. Dr. Belgin Sever, Dr Fatih Demirci

  53. Potential inhibitors of human carbonic anhydrase isozymes I and II: Design, synthesis and docking studies of new 1,3,4-thiadiazole derivatives

    Article • Bioorganic & Medicinal Chemistry, July 2017, Elsevier

    Assoc. Prof. Dr. Belgin Sever

  54. Synthesis and Evaluation of New Thiazolyl Hydrazone Derivatives as Potential Anticancer Agents

    Article • Letters in Drug Design & Discovery, June 2017, Bentham Science Publishers

    Assoc. Prof. Dr. Belgin Sever

  55. Synthesis and Evaluation of A New Series of Thiazole Derivatives as Potential Antitumor Agents and MMP Inhibitors

    Article • Anti-Cancer Agents in Medicinal Chemistry, April 2017, Bentham Science Publishers

    Assoc. Prof. Dr. Belgin Sever, Dr Fatih Demirci

  56. Synthesis and evaluation of new benzodioxole-based dithiocarbamate derivatives as potential anticancer agents and hCA-I and hCA-II inhibitors

    Article • European Journal of Medicinal Chemistry, January 2017, Elsevier

    Assoc. Prof. Dr. Belgin Sever

  57. Mechanisms, Clinical Strategies, and Promising Treatments of Neurodegenerative Diseases. 13th International Conference AD/PDTM Vienna, Austria, March 29 to April 2, 2017: Abstracts

    Article • Neurodegenerative Diseases, January 2017, Karger Publishers

    Assoc. Prof. Dr. Belgin Sever

  58. Synthesis and Evaluation of New Benzodioxole- Based Thiosemicarbazone Derivatives as Potential Antitumor Agents

    Article • Molecules, November 2016, MDPI AG

    Assoc. Prof. Dr. Belgin Sever

  59. Indomethacin based new triazolothiadiazine derivatives: Synthesis, evaluation of their anticancer effects on T98 human glioma cell line related to COX-2 inhibition and docking studies

    Article • European Journal of Medicinal Chemistry, May 2016, Elsevier

    Assoc. Prof. Dr. Belgin Sever

  60. Synthesis andIn VitroEvaluation of New Thiosemicarbazone Derivatives as Potential Antimicrobial Agents

    Article • Journal of Chemistry, January 2016, Hindawi Publishing Corporation

    Assoc. Prof. Dr. Belgin Sever

  61. SYNTHESIS AND EVALUATION OF BENZODIOXOLE APPENDED PYRAZOLINE DERIVATIVES AS NEW ANTIMICROBIAL AGENTS

    Article • ANADOLU UNIVERSITY JOURNAL OF SCIENCE AND TECHNOLOGY –C Life Sciences and Biotechnology, December 2015, Anadolu Universitesi Bilim ve Teknoloji Dergisi C : Yasam Bilimleri ve Biyoteknoloji

    Assoc. Prof. Dr. Belgin Sever

  62. Synthesis and Evaluation of Tetrazole-BasedHydrazone Derivatives Bearing a Pyridine Moiety as Antimicrobial Agents

    Article • Letters in Drug Design & Discovery, July 2015, Bentham Science Publishers

    Assoc. Prof. Dr. Belgin Sever

  63. Synthesis and evaluation of naphthalene-based thiosemicarbazone derivatives as new anticancer agents against LNCaP prostate cancer cells

    Article • Journal of Enzyme Inhibition and Medicinal Chemistry, March 2015, Taylor & Francis

    Assoc. Prof. Dr. Belgin Sever

  64. Eskişehir’de Eczane Teknisyenleri üzerine Bir Araştırma

    Article • Cukurova Medical Journal (Çukurova Üniversitesi Tıp Fakültesi Dergisi), January 2014, Cukurova Medical Journal

    Assoc. Prof. Dr. Belgin Sever

  65. Studies On Thiazolyl-Hydrazone Derivatives As Acetylcholinesterase Inhibitors

    Article • Journal of Marmara University Institute of Health Sciences, January 2014, AVES Publishing Co.

    Assoc. Prof. Dr. Belgin Sever